Merck · 1 day ago
Associate Principal Scientist, Research Science
Merck is seeking an energetic and highly motivated Scientist in Antibody Engineering. The role focuses on antibody discovery, optimization, and characterization, collaborating with cross-functional teams to advance therapeutic antibodies and novel biologics.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Design and initiate target-focused antibody discovery strategies
Design, develop and optimize selection methods to enrich for affinity, specificity, cross‑reactivity, and epitope diversity
Interface with CROs or platform vendors for immunization or display campaigns as needed
Conduct affinity maturation, speciation (e.g. caninization/felinization), and specificity engineering (e.g., CDR grafting, back‑mutation, structure‑guided design)
Engineer formats including Fabs, scFvs, VHHs, bispecifics, multispecifics, and Fc variants for tailored effector functions and half‑life
Apply in silico tools for sequence liability assessment, developability predictions, and structure modeling
Work with other team members to characterize biophysical and biochemical properties
Assess binding by ELISA, SPR/BLI, flow cytometry
Perform epitope binning/mapping and cross‑species reactivity
Collaborate with biology teams to evaluate potency, MOA, and functional readouts
Work with CMC teams to screen for developability (solubility, stability, aggregation, viscosity, PTM liabilities) and implement sequence fixes
Provide input on sequence selection and manufacturability risks
Plan, prioritize, and execute experiments; analyze data and present in cross‑functional forums
Author study reports and contribute to patent filings and regulatory documents
Mentor junior associates and help implement best practices and data management
Apply knowledge of key signal transduction pathways to design appropriate assay systems for characterization of biological and pharmacological effects of new veterinary therapeutics
Develop and manage project specific milestones and timelines
Manage the R&D relationships with external service providers
Prepare progress reports and make presentations to stakeholders
Stay informed of external advances & technologies to enhance the product development portfolio
Communicate progress and plans to a variety of stakeholders with diverse expertise
Provide support, coaching or assistance to other team members
Qualification
Required
Ph.D. in a biological discipline
3+ years relevant work experience in antibody discovery/engineering
Demonstrated experience with at least one display platform (phage, yeast, or mammalian) or immunization‑based antibody discovery
Hands‑on expertise in antibody engineering (speciation, affinity maturation, specificity tuning, format engineering)
Proficiency in biomolecular interaction methods and analytical characterization (e.g., SPR/BLI)
Proficiency with developability assessment and mitigation of sequence liabilities (e.g., deamidation, isomerization, oxidation, glycosylation hotspots)
Strong data analysis and documentation skills
Proficiency with molecular biology and sequence design tools (e.g., Geneious, MOE/Rosetta, IgBLAST/IMGT)
Ability to interpret and analyze data from key biological, biochemical and immunological assay systems and design appropriate follow-on experiments
Ability to contribute or manage more than one project at a time
Excellent communication and cross‑functional collaboration skills
Preferred
Experience with bispecific/multispecific formats
Experience with Fc engineering for effector function and half‑life
Experience with computational antibody design
Familiarity with early CMC and developability workflows
Experience managing CROs or external partners
Benefits
Medical
Dental
Vision healthcare
Other insurance benefits (for employee and family)
Retirement benefits, including 401(k)
Paid holidays
Vacation
Compassionate and sick days
Company
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Funding
Current Stage
Public CompanyTotal Funding
$5.59MKey Investors
Private Capital AdvisorsGavi, the Vaccine Alliance
2018-11-25Post Ipo Equity· $0.59M
2016-01-21Series Unknown· $5M
1980-12-19IPO
Leadership Team
Recent News
2026-01-08
2026-01-08
2026-01-08
Company data provided by crunchbase